Beta Drugs Limited Share Price & Analysis
₹2218.50−1.79%Updated 4 Sept 2026, 03:30 pm IST
LTP
₹2218.50−1.79%Open
₹2246.10High
₹2270.00Low
₹2190.10Close
₹2218.5052W High
₹2808.0052W Low
₹990.00Volume
13KLot Size
1Sector
HealthcareMarket Cap
₹2K CrFace Value
₹10Small Cap
Price Chart
Candle
Range
Fundamentals
P/E
54.00Sector P/E
54.70P/B
5.86EPS
₹40.85ROE
18.80%ROCE
19.20%D/E Ratio
0.60Div Yield
0.00%Book Value
₹241.00Strengths
- Strong return on equity (ROE 18.8%)
- Efficient capital deployment (ROCE 19.2%)
Concerns
Peer Comparison
| Company | CMP | Mkt Cap | P/E | P/B | ROE % | ROCE % | D/E |
|---|---|---|---|---|---|---|---|
| SUNPHARMA Sun Pharmaceutical Industries Limited | ₹1,899 | ₹4.6L Cr | 36.1 | 5.46 | 16 | 20.5 | 0.07 |
| DIVISLAB Divi's Laboratories Limited | ₹9,100 | ₹2.4L Cr | 81.1 | 14.42 | 16.5 | 22 | 0.01 |
| TORNTPHARM Torrent Pharmaceuticals Limited | ₹4,857 | ₹1.8L Cr | 82.8 | 19.58 | 27.4 | 15.2 | 0.33 |
| APOLLOHOSP Apollo Hospitals Enterprise Limited | ₹8,650 | ₹1.2L Cr | 59.1 | 13.13 | 21.2 | 17.4 | 0.88 |
| CIPLA Cipla Limited | ₹1,385 | ₹1.1L Cr | 31.3 | 3.25 | 11.6 | 15.5 | 0.01 |
| ZYDUSLIFE Zydus Lifesciences Limited | ₹1,120 | ₹1.1L Cr | 23 | 4.16 | 21.2 | 21.1 | 0.38 |
| LAURUSLABS Laurus Labs Limited | ₹1,840 | ₹99K Cr | 90.9 | 18.74 | 18.3 | 17.8 | 0.46 |
Showing 7 peers in the same sector · Sorted by market cap
Shareholding Pattern
BETA · as of Dec 2025
Promoters66.73%
FII1.15%0.01pp
DII0.17%0.01pp
Public31.95%
| Category | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoters | 66.73% | 66.73% | 66.73% | 66.73% | 66.73% | 66.73% |
| FII | 0.32% | 0.32% | 0.32% | 0.90% | 1.16% | 1.15% |
| DII | 0.02% | 0.02% | 0.06% | 0.12% | 0.16% | 0.17% |
| Public | 32.93% | 32.92% | 32.87% | 32.25% | 31.95% | 31.95% |
About Beta Drugs Limited
Beta Drugs Ltd is engaged in manufacturing of a wide range of oncology (anti-cancer) drugs in India. It has operations in the domestic and export markets.[1]
HealthcarePharmaceuticals & Biotechnology
Related Analysis
Frequently Asked Questions
What is Beta Drugs Limited share price today?
Beta Drugs Limited (BETA) is currently trading at ₹2,218.5 on NSE, down 1.79% as of the last market session. Prices update daily after market close on MarketNetra.
Is Beta Drugs Limited available in F&O (Futures & Options)?
Yes, Beta Drugs Limited (BETA) is part of the NSE F&O segment with a lot size of 1 shares. Options are available with monthly expiry contracts. You can track the full option chain and OI analysis on MarketNetra.
What is Beta Drugs Limited 52-week high and low?
Beta Drugs Limited's 52-week high is ₹2,808 and the 52-week low is ₹990. The current price of ₹2,218.5 is 21.0% below the 52W high.
What is Beta Drugs Limited P/E ratio?
Beta Drugs Limited's current P/E ratio is 54. This indicates the market is paying ₹54 for every ₹1 of earnings. Compare this to the sector average to assess relative valuation.
How to trade Beta Drugs Limited options?
Beta Drugs Limited options are traded on NSE with monthly expiry contracts (lot size: 1 shares). To trade BETA options: select your expiry on the option chain page, identify key OI strikes, check the PCR and buildup type on OI analysis, and review FII/DII flows for institutional sentiment before taking a position.